Season 2

For the chronic disease community, 2022 is set to be a major year of health policy. On this episode, Republican and Democrat political experts weigh in on what’s on the horizon for healthcare policies in the new year. Matt Rodriguez, …

A doctor knows their patients’ needs best. But too often, insurance gets in the way. In an effort to lower costs, insurers sometimes force stable patients off of prescribed medication to a cheaper option. It’s called non-medical switching, and can...

Have you received an unfair medical bill? You’re not alone. Many patients have faced high bills that are simply incorrect, or even predatory. But let’s face it, even understanding complex and confusing bills is a huge challenge. Patients Rising...

Today’s medical research and development creates the cures of tomorrow. But it requires immense amounts of funding to develop safe and effective drugs, treatments, and medical devices. In the rare disease space, funding is in short supply. Hear how...

The Senate faces a race to the end of the year with a mountain of healthcare policies on its plate. Taking center stage is the House’s version of the Build Back Better plan. But it’s likely to undergo several changes, …

Half of individuals with health insurance are covered by their employer. If you are in this group, this episode is a must-listen. Learn how benefit design impacts your out-of-pocket expenses, your in-network providers, and the care available to you....

Cold and flu season is here. If you are immunocompromised, respiratory infections pose an even greater risk. Antibiotics are a common go-to solution, but there’s a catch: the more we use them, the less effective they become. Dr. John Rex …

This Veteran’s Day, hosts Terry and Dr. Bob explore potential federal policies to improve healthcare for U.S. veterans. Congresswoman Nancy Mace (SC-01) serves on the Veterans Affairs Committee and she joins the show to share what Congress can do to...

Hosts Terry and Dr. Bob catch up with patient advocates following their virtual meetings on Capitol Hill. Patients Rising Now Patient Advocacy Day, held at the end of October, had patients and caregivers sharing their healthcare stories and asking for...

No two patients are the same, so often care teams can’t predict a treatment outcome from one patient to the next. That’s where biomarker testing comes in: the first step in personalized medicine. Biomarker tests help physicians identify...

Congress promises to lower drug prices. But patients won’t see any cost savings at the pharmacy counter. We sort through the facts and myths of drug pricing, how “middlemen” in the supply chain lead to higher costs and real solutions …

COVID-19 continues to put the most vulnerable at risk, including the elderly and those with chronic illnesses. At its peak, it filled up hospitals and forced those seeking non-COVID care to postpone critical appointments. To protect patients and...

Patients depend on the research and development cycle to produce innovative, life saving medicines for rare and chronic conditions. But this medical innovation faces hurdles if Congress passes medicare price negotiations within the Build Back Better...

Numerous health policies are under debate in Congress. As Senators and Representatives hash out drug pricing legislation and more, where are patients in the conversation? Advocate and former Ohio state legislator Randi Clites shares how patients can...

As Congress continues to debate solutions to lower healthcare costs, biosimilars are a promising option. But uptake of biosimilars has been slow in the U.S., and few patients are seeing direct savings at the pharmacy counter. Brian Lehman, Director of...

President Biden outlines a new COVID-19 strategy, the U.S. Senate returns to Washington, and the House of Representatives debates prescription drug prices. Hosts Terry Wilcox and Dr. Bob Goldberg break down D.C.’s busy week and what chronic disease...

Want greater access to your doctor at a lower price? It’s possible through direct primary care. This healthcare solution allows patients to develop personal relationships with their doctors and receive care quicker and cheaper. Three physicians...

What can Congress do to aid in the fight against ovarian cancer? If reauthorized, Johanna’s Law would increase funding for ovarian cancer education and awareness programs. Ovarian Cancer Research Alliance’s VP of Policy, Chad Ramsey,...

Kids across the country are headed back to school. But as the Delta variant spreads, what should families living with chronic disease know to stay healthy and safe? Pediatrician Dr. Marlene Wust-Smith gives a back-to-school c...

What’s the purpose of a patent? In the pharmaceutical industry, it helps manufacturers reinvest in new research and development to improve upon treatments and drugs. It’s a key part of the cycle of developing new treatments. ...

Premiums, deductibles, and copays continue to rise as insurance companies grow fat through mergers and monopolies. Host Terry Wilcox speaks with former insurance executive-turned-advocate Wendell Potter. Together, they explor...

The Delta variant, a breakdown of the FDA’s accelerated approval process, and how pink socks are bringing together patient advocacy groups. Hosts Dr. Bob Goldberg and guest host Kate Pecora dive into the news of the week, inc...

Opioid overdoses are rising as the COVID-19 pandemic continues. In 2020, overdose deaths rose by 30%. However, many chronic disease patients rely on prescription opioids for their healthcare regimen. We examine a balanced pol...

The high price tag for a new Alzheimer’s drug has fueled the ongoing drug price debate. But will patients really pay sticker price? (Spoiler alert: No!). Co-host Dr. Bob Goldberg explains the research/value assessment of the ...